Sign in to view content

Results From Part 1 of the Phase 2/3 SIGLEC Trial Assessing AVD-104 for Geographic Atrophy: Glyco-immunologic Modulation of Macrophage Activity

Rishi P. Singh, MD

Video
Published 2024

Related

Anatomic Changes Following a Single Injection of AVD-104 in Patients With GA Secondary to AMD in the SIGLEC Study
David S. Boyer, MD
Annual Meeting Talks
2024
Quantitative Contrast Sensitivity Longitudinal Changes Correlate Better Than Visual Acuity With Geographic Atrophy Progression
John B. Miller, MD
Annual Meeting Talks
2024
The MOSAIC Study: A Clinical and Humanistic Burden of Illness Study of Patients With GA and Their Caregivers in the United States and Canada
Sophie Jane Bakri, MD
Annual Meeting Talks
2023

Category: AMD-Non-Neovascular

See more